Edwards Lifesciences Corporation (FRA:EWL)

Edwards Lifesciences Revenue

Edwards Lifesciences had revenue of $1.41B USD in the quarter ending March 31, 2025, with 4.89% growth. This brings the company's revenue in the last twelve months to $5.52B, down -9.68% year-over-year. In the year 2024, Edwards Lifesciences had annual revenue of $5.44B with 8.57% growth.

• Revenue (ttm): $5.52B
• Revenue Growth: -9.68%
• P/S Ratio: 7.67
• Revenue / Employee: $349.51K
• Employees: 15,800
• Market Cap: 39.20B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.44B	429.50M	8.57%
Dec 31, 2023	5.01B	546.00M	12.23%
Dec 31, 2022	4.46B	-768.50M	-14.69%
Dec 31, 2021	5.23B	846.20M	19.29%
Dec 31, 2020	4.39B	38.30M	0.88%